What are the normal reference ranges for routine blood investigations in adults?

Normal Reference Ranges for Routine Blood Investigations in Adults

For routine clinical practice, use hemoglobin < 13.5 g/dL in adult males and < 12.0 g/dL in adult females to define anemia, HbA1c reference range of 4.0–6.0% (20–42 mmol/mol), and TSH 0.4–4.12 mIU/L for thyroid function assessment. 1, 2, 3

Hematology Parameters

Hemoglobin and Red Blood Cells

• Hemoglobin: Males 13.5–17.5 g/dL; Females 12.0–16.0 g/dL 1
• Red blood cell count: Males 4.5–6.0 × 10¹²/L; Females 4.0–5.5 × 10¹²/L 4, 5
• Hematocrit: Males 40–52%; Females 36–48% 1, 4
• Mean corpuscular volume (MCV): 80–100 fL 5, 6
• Mean corpuscular hemoglobin (MCH): 27–33 pg 5, 6
• Mean corpuscular hemoglobin concentration (MCHC): 32–36 g/dL 5, 6

Critical interpretation point: The anemia threshold of < 13.5 g/dL in males (rather than the WHO's < 13.0 g/dL) accounts for the fact that older males with lower hemoglobin often have concurrent pathological conditions contributing to anemia, and no age-adjustment downward should be made. 1 In females, the < 12.0 g/dL threshold reflects exclusion of iron deficiency states. 1

White Blood Cells

• Total WBC count: 4.0–11.0 × 10⁹/L 4, 5, 7
• Neutrophils: 40–70% (2.0–7.5 × 10⁹/L) 5, 8
• Lymphocytes: 20–45% (1.0–4.0 × 10⁹/L) 5, 8
• Monocytes: 2–10% (0.2–1.0 × 10⁹/L) 5, 8
• Eosinophils: 1–6% (0.04–0.4 × 10⁹/L) 5, 8
• Basophils: 0–2% (0.01–0.1 × 10⁹/L) 5, 8

Important caveat: Absolute neutrophil count (ANC) thresholds of > 1,500/μL used in many clinical trials can exclude patients with benign ethnic neutropenia, particularly affecting Black and Asian populations who may have baseline ANC of 1,000–1,500/μL without increased infection risk. 9 Lowering ANC eligibility to ≥ 1,000/μL is more appropriate for diverse populations. 9

Platelets

• Platelet count: 150–400 × 10⁹/L 4, 5, 7
• Platelet count decreases by approximately 20,000/μL between the sixth and eighth decades of life. 9

Glucose Metabolism

Fasting Plasma Glucose

• Normal: < 100 mg/dL (< 5.6 mmol/L) 10
• Pre-diabetes: 100–125 mg/dL (5.6–6.9 mmol/L) 10
• Diabetes: ≥ 126 mg/dL (≥ 7.0 mmol/L) on two separate occasions 10

Day-to-day variability: Fasting glucose has 12–15% variance, necessitating two separate elevated measurements for diabetes diagnosis. 10 Random glucose ≥ 140–180 mg/dL has high specificity (92–98%) but low sensitivity (39–55%) for diabetes. 10

Hemoglobin A1c (HbA1c)

• Reference range: 4.0–6.0% (20–42 mmol/mol), with mean ≈ 5.0% (31 mmol/mol) 2, 10
• Pre-diabetes: 5.7–6.4% (39–47 mmol/mol) 2
• Diabetes: ≥ 6.5% (≥ 48 mmol/mol) 2, 10

Assay requirements: HbA1c methods must be NGSP-certified and traceable to the DCCT reference assay; point-of-care devices are not appropriate for diagnostic use. 2, 10 Reference intervals should not deviate substantially (> 0.5%) from a mean of 5.0% (31 mmol/mol), i.e., 4.5–5.5% (26–37 mmol/mol). 2, 10

Interpretation limitations: Small changes of ± 0.3% may reflect analytical variability rather than true glycemic change. 2, 10 HbA1c is unreliable in anemia, hemoglobinopathies, end-stage renal disease on dialysis, and conditions altering red-cell lifespan. 11, 10

Glycated Albumin (GA)

• Reference range: 11–17% (reflects 2–3 week glycemic average) 11, 10
• GA is unreliable in nephrotic syndrome, cirrhosis, abnormal thyroid function, and disorders modifying albumin turnover. 11, 10

Renal Function

Serum Creatinine

• Males: 0.7–1.3 mg/dL (62–115 μmol/L) 9, 10
• Females: 0.5–1.1 mg/dL (44–97 μmol/L) 9, 10
• Asian females: 0.43–0.88 mg/dL (lower than White females) 9

Population differences: Formulas estimating glomerular filtration rate (e.g., Cockcroft-Gault) often underestimate true creatinine clearance, especially in females and those with lower muscle mass. 9 In cancer populations, 50% have CrCl < 90 mL/min and 20% have CrCl < 60 mL/min. 9

Blood Urea Nitrogen (BUN)

• Reference range: 7–20 mg/dL (2.5–7.1 mmol/L) 10
• BUN varies with age, hydration status, and protein intake; interpret in clinical context. 10

Liver Function Tests

Transaminases

• Alanine aminotransferase (ALT): Males 10–79 U/L; Females 10–55 U/L 9, 10
• Aspartate aminotransferase (AST): Males 10–40 U/L; Females 10–35 U/L 9, 10

Clinical significance: ALT is more liver-specific than AST; initial screening should include ALT rather than both transaminases. 10 An AST:ALT ratio > 1 suggests advanced fibrosis or cirrhosis, whereas a ratio > 2 should prompt evaluation for non-hepatic sources such as hemolysis or myopathy. 10 In infants, AST:ALT > 2 raises suspicion for hemolysis or myopathy rather than primary liver disease. 10

Common trial exclusion pitfall: Transaminase thresholds of 2–2.5 × ULN exclude many patients who may have adequate hepatic synthetic and clearance function but elevated transaminases due to liver metastases. 9 FDA guidance suggests patients with transaminase elevation up to 20 × ULN may have similar tolerance to therapies as those with normal levels. 9

Bilirubin and Synthetic Function

• Total bilirubin: 0.3–1.2 mg/dL (5–21 μmol/L); males have significantly higher concentrations than females 9, 10
• Direct (conjugated) bilirubin: 0–0.3 mg/dL (0–5 μmol/L) 10
• Serum albumin: 3.5–5.0 g/dL (35–50 g/L); serves as marker of hepatic synthetic capacity 10

Alkaline Phosphatase and GGT

• Alkaline phosphatase (ALP): 30–120 U/L (age- and gender-specific ranges essential) 9, 10
• ALP increases by 20% between the 3rd and 8th decade. 9
• Gamma-glutamyl transferase (GGT): 5–55 U/L 10
• Adding GGT to routine panels improves liver disease detection but increases false-positive results from 15% to 30%. 10

Thyroid Function

Thyroid-Stimulating Hormone (TSH)

• Reference range: 0.4–4.12 mIU/L (based on NHANES III data) 3, 12
• Mean and median: Approximately 1.5 mIU/L 3

Controversy regarding upper limit: Some advocate for an upper limit of 2.5–3.0 mIU/L because the TSH distribution is right-skewed by values between 3.1–4.12 mIU/L, and the mean/median are much closer to the lower limit. 3 However, adopting 2.5 mIU/L as the upper limit would lead to > 10 million additional hypothyroidism diagnoses in the U.S. without clear clinical benefit, as individual TSH measurements vary up to 50% above and below the mean on a given day. 3

Age considerations: TSH reference values in elderly populations remain controversial; some studies show slight increases with age while others do not. 12 The consensus is to continue using 0.4–4.0 mIU/L as the reference interval across all adult ages. 12

Treatment target: For patients on levothyroxine, target TSH within the normal range (0.45–4.12 mIU/L), not specifically to low-normal or subnormal levels, as data supporting clinical benefit of such targeting are lacking. 3

Lipid Panel

• Total cholesterol: < 200 mg/dL (< 5.2 mmol/L) desirable 11, 10
• LDL cholesterol: < 100 mg/dL (< 2.6 mmol/L) for adults without ASCVD; < 70 mg/dL (< 1.8 mmol/L) for those with ASCVD 11, 10
• HDL cholesterol: ≥ 40 mg/dL (≥ 1.0 mmol/L) in males; ≥ 50 mg/dL (≥ 1.3 mmol/L) in females; values ≤ 0.91 mmol/L (≤ 35 mg/dL) increase diabetes and cardiovascular risk 11, 10
• Triglycerides: < 150 mg/dL (< 1.7 mmol/L); levels ≥ 2.22 mmol/L (≥ 200 mg/dL) constitute a diabetes risk factor 11, 10

Population differences: Black participants have significantly lower total cholesterol and triglycerides, and higher HDL compared to Whites. 9

Prostate-Specific Antigen (PSA)

Age-Specific Reference Ranges

• 40–49 years: Asian-Americans 0–2.0 ng/mL; African-Americans 0–2.0 ng/mL; Whites 0–2.5 ng/mL 13
• 50–59 years: Asian-Americans 0–3.0 ng/mL; African-Americans 0–4.0 ng/mL; Whites 0–3.5 ng/mL 13
• 60–69 years: Asian-Americans 0–4.0 ng/mL; African-Americans 0–4.5 ng/mL; Whites 0–4.5 ng/mL 13
• 70–79 years: Asian-Americans 0–5.0 ng/mL; African-Americans 0–5.5 ng/mL; Whites 0–6.5 ng/mL 13

Median values by age: 0.7 ng/mL for men in their 40s, 0.9 ng/mL in their 50s, 1.2 ng/mL in their 60s, and 1.5 ng/mL in their 70s. 13

Special Considerations

Altitude Adjustment for Hemoglobin

Hemoglobin increases by approximately 0.6 g/dL in women and 0.9 g/dL in men for each 1,000 m of altitude above sea level. 1 At 1,000 m altitude, add 0.2 g/dL; at 2,000 m, add 0.8 g/dL; at 3,000 m, add 1.9 g/dL to the anemia threshold. 1

Racial and Ethnic Differences

Among 38 standard laboratory tests in NHANES, only five (glucose, phosphorus, potassium, total bilirubin, and uric acid) did not show significant racial/ethnic differences. 9 Black participants have significantly higher CPK, globulin, and total protein, and lower hematocrit, hemoglobin, total cholesterol, triglycerides, and WBC than Whites. 9 The lower limit of normal for hemoglobin is 9.6 g/dL in Black women, which falls below many clinical trial eligibility thresholds. 9

Verification of Extreme Values

Laboratories should verify by repeat testing specimens with HbA1c results below the lower limit of the reference interval or > 15% (140 mmol/mol). 2, 10 If possible, repeat measurement should use a method based on a different analytical principle. 2, 10 Results < 4% (20 mmol/mol) or > 15% HbA1c should prompt consideration of hemoglobin variants. 2